Feds pay $137 million for Pfizer’s COVID-19 trials with primates
Texas Biomed, a Biolab in San Antonio, Texas, will receive $137 million for 17 COVID-19 research projects for Pfizer, a pharmaceutical company.
Starting in December, one grant was for $100 million, payable over five years.
https://www.highergov.com/idv/75A50122D00020/
Another $37 million was paid two years ago.
Money from Congress.
The Department of Health & Human Services (DHH), a federal agency, paid the grants.
Texas Biomed does Pfizer’s COVID-19 research using primates instead of humans.
Primates used in their trials were immune to COVID-19.
Pfizer failed to disclose that information to the FDA and people before they got their experimental COVID-19 shots.
The FDA is the Food & Drug Administration, a non-government pharmaceutical business.
https://issuu.com/texasbiomed/docs/txbiomed-summer-2022/s/16333805
Sources are:
Isis Kanvesky, Pfizer’s Director of Vaccine Research and Development
Larry Schlesinger, CEO, Texas Biomedical Research Center
Deepak Kaushal, Director of the Southwest National Primate Research Center of the Texas Biomedical Research Center
Dr. Tedros Adhanom Ghebreyesus, Director, World Health Organization (WHO)
Below is text imaged from the above story in the San Antonio Express-News:
